Opus Genetics (IRD) Treasury Shares (2010 - 2026)
Opus Genetics (IRD) posted quarterly Treasury Shares of $128410.0 for Q3 2015, little changed year-over-year from $128410.0 in Q3 2014, and little changed quarter-over-quarter from $128410.0 in Q2 2015.
Opus Genetics (IRD) Treasury Shares (2010 - 2026) Analysis & Trends
Opus Genetics (IRD) has reported Treasury Shares for 6 consecutive years, with $128410.0 the latest figure, recorded in Q3 2015.
- In Q3 2015, Treasury Shares changed 0.0% year-over-year to $128410.0; the TTM figure through Sep 2015 stood at $128410.0 (changed 0.0% YoY), while the FY2014 annual figure was $128410.0, up 351.99% from the prior year.
- Treasury Shares held at $128410.0 in Q3 2015 per IRD's latest filing, from $128410.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $29.4 million in Q1 2025 and bottomed at $801700.0 in Q1 2023.
- Historically, Treasury Shares has averaged $19.5 million across 4 years, with a median of $22.9 million in 2025.
- Annual changes were most pronounced in 2011 — Treasury Shares changed 0.0% — and 2014, when it jumped 351.99%.
- Opus Genetics' Treasury Shares stood at $28410.0 in 2011, then changed by 0.0% to $28410.0 in 2012, then changed by 0.0% to $28410.0 in 2013, then jumped by 351.99% to $128410.0 in 2014, then changed by 0.0% to $128410.0 in 2015.
- Business Quant data shows IRD's Treasury Shares at $128410.0 in Q3 2015, $128410.0 in Q2 2015, and $128410.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - | 19.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.62 Mn |
| Jun 30, 2026 | 19.62 Mn |
| Mar 31, 2026 | 22.90 Mn |
| Mar 31, 2026 | 22.90 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 29.43 Mn |
| Sep 30, 2025 | 29.43 Mn |
| Jun 30, 2025 | 29.43 Mn |
| Jun 30, 2025 | 29.43 Mn |
| Mar 31, 2025 | 29.43 Mn |
| Mar 31, 2025 | 29.43 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Mar 31, 2023 | 801,700.00 |
| Mar 31, 2023 | 801,700.00 |
| Dec 31, 2020 | 40,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Jun 30, 2019 | 271.00 |
| Jun 30, 2019 | 271.00 |